Idera Pharmaceuticals Inc. (toll-like receptor (TLR) antagonists for autoimmune diseases and B-cell lymphomas) signed on Abbott Laboratories Inc. to develop a companion in vitro diagnostic for use with its Phase II IMO8400 B-cell lymphoma program. (May)
Deals Shaping The Medical Industry, June 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April through May 2014.